Table 2: Antithrombotic therapy before and after left atrial appendage closure.

PretreatmentPosttreatment, dischargePosttreatment, 3 monthsPosttreatment, 6/12 months

n68686862
No antithrombotic therapy16 (23.5%)5 (7.3%)10 (14.7%)20 (32.3%)
Single anti-platelet therapy12 (17.7%)29 (42.7%)40 (58.9%)34 (54.8%)
Dual anti-platelet therapy23 (33.8%)32 (47.1%)16 (23.5%)8 (12.9%)
Anticoagulant therapy17 (25.0%)2 (2.9%)2 (2.9%)0 (0.0%)